Valuing a Pharmaceutical Asset: a new, data-rich tool for estimating a drug's true value (US)
Date
October 11, 2018
2:00PM
Calendar

With approval rates declining and clinical trial costs soaring, it’s difficult to accurately value a pharmaceutical product in development. Now there’s a new technology platform that aims to drive more accurate, data driven valuations. Pipeline Architect builds on IQVIA’s massive data sets on clinical trial timing, costs, revenues and success rates, to value an asset quickly and accurately. Whether you need to value a new business development or licensing deal, or determine the value of your own products in development, Pipeline Architect delivers best-in-class asset valuations.

Contact Us
Contact Us

Email Us

Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?

Call Us

We're available during standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.

Media Inquiries

Please note that forms have been updated on SC9 PROD, it may be good to update the SC9 DEV forms with SC9 PROD.